Jaume Pons

Founder at

Alx Oncology Ltd.

Net worth: 939 966 $ as of 31/05/2026

60 year

92 connections

Health Technology

Consumer Services

Finance

Profile

Jaume Pons is the founder of ALX Oncology Ltd., founded in 2015, serving as President, Chief Executive Officer & Director.
Dr. Pons was the founder of ALX Oncology Holdings, Inc., founded in 2015, serving as President & Chief Scientific Officer from 2024 to 2025.
Dr. Pons is also the founder of ALX Oncology, Inc.,Tallac Therapeutics, Inc...
Dr. Pons currently serves as Director at Alexo Therapeutics International and Sirpant Therapeutics.
Dr. Pons is Scientific Advisor at LSV Capital Management LLC.
Dr. Pons is Venture Partner at venBio Partners LLC since 2015.
Formerly, Dr. Pons was Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
Dr. Pons was Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed graduate studies at the University of California, Berkeley.
Dr. Pons completed undergraduate, graduate, and doctorate degrees at the Autonomous University of Barcelona.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALX ONCOLOGY HOLDINGS, INC. 0.37%	31/03/2026	494,719 ( 0.37% )	939 966 $	31/05/2026

Jaume Pons active positions

Companies	Position	Start
venBio Partners LLC venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor.	Private Equity Investor	04/01/2015
Alx Oncology Ltd. Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer	Founder	01/04/2015
Alexo Therapeutics International Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA.	Director/Board Member	-
Tallac Therapeutics, Inc. Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides	Founder	-
Sirpant Therapeutics	Director/Board Member	-
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Consultant / Advisor	-

All active positions of Jaume Pons

Former positions of Jaume Pons

Companies	Position	End
ALX ONCOLOGY HOLDINGS INC.	Chief Executive Officer	06/09/2023
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases	Chief Tech/Sci/R&D Officer	01/02/2015
ALX Oncology, Inc. ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers	Chief Executive Officer	-
░░░░░░ ░░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	-

See the detail of Jaume Pons's experience

Training of Jaume Pons

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaume Pons's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rinat Neuroscience Corp. Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases	Health Technology
venBio Partners LLC venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor.	Finance
Autonomous University of Barcelona Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Finance
Alx Oncology Ltd. Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer	Health Technology
ALX Oncology, Inc. ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers	Health Technology
Tallac Therapeutics, Inc. Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides	Health Technology
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology
Alexo Therapeutics International Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA.	Health Technology
Sirpant Therapeutics